Non-Narcotic Cough Syrup Recommendations
Dextromethorphan 30-60 mg every 4-12 hours is the recommended first-line non-narcotic antitussive for dry cough, with honey and lemon as an equally effective non-pharmacological alternative; for productive cough, guaifenesin is the preferred expectorant. 1, 2, 3
For Dry, Non-Productive Cough
First-Line Non-Pharmacological Approach
- Honey and lemon mixture should be tried first as it is simple, inexpensive, and has evidence of patient-reported benefit without adverse effects 1, 2, 3
- This approach is particularly appropriate for benign viral cough 1
First-Line Pharmacological Agent: Dextromethorphan
- Dextromethorphan is the preferred non-narcotic antitussive due to its superior safety profile compared to codeine-based alternatives 1, 2, 3
- Effective dosing is 30-60 mg, with maximum cough reflex suppression occurring at 60 mg 1, 2, 3
- Standard over-the-counter doses (15-30 mg) are often subtherapeutic and may be inadequate 1, 2
- Maximum daily dose should not exceed 120 mg 2
- Duration should be limited to short-term use (typically less than 7 days) 1, 2, 3
- FDA-approved dosing for adults and children ≥12 years: 10 mL every 12 hours, not exceeding 20 mL in 24 hours 4
Critical Safety Considerations for Dextromethorphan
- Check combination products carefully as some contain acetaminophen or other ingredients that can accumulate to toxic levels with higher dextromethorphan doses 2
- Dextromethorphan is safe in elderly patients with chronic kidney disease as it does not require dose adjustment for renal impairment 2
- Abuse potential exists, particularly in teenagers, though it is generally safe at recommended dosages 5
Adjunctive Options for Nocturnal Cough
- First-generation antihistamines (diphenhydramine, chlorpheniramine, or promethazine) can be added specifically for nocturnal cough due to their sedative properties 1, 3
- Use with caution in elderly patients due to anticholinergic effects (avoid in those with cognitive impairment, urinary retention, or fall risk) 2
Alternative Non-Pharmacological Options
- Menthol by inhalation provides acute but short-lived cough suppression 1, 3
- Voluntary cough suppression through central modulation may reduce cough frequency 3
For Productive, Wet Cough
Expectorant: Guaifenesin
- Guaifenesin is the recommended non-narcotic expectorant to help clear secretions 2
- FDA-approved dosing for adults and children ≥12 years: 10-20 mL (2-4 teaspoonfuls) every 4 hours, not exceeding 6 doses in 24 hours 6
- Do not suppress productive cough with antitussives as secretion clearance is beneficial 2, 3
Alternative for Bronchitis
- Hypertonic saline solution is recommended on a short-term basis to increase cough clearance in patients with bronchitis 7, 2
- Ipratropium bromide (inhaled) is effective for cough suppression in chronic bronchitis 2, 3
What NOT to Use (Non-Narcotic Alternatives to Avoid)
- Codeine and pholcodine should never be prescribed despite being non-narcotic in some classifications, as they have no greater efficacy than dextromethorphan but significantly higher adverse effect profiles 2, 3
- Over-the-counter combination cold medications (except older antihistamine-decongestant combinations) are not recommended until proven effective 7
- Albuterol is not recommended for cough not due to asthma 7
- Zinc preparations are not recommended for acute cough due to common cold 7
Age-Specific Considerations
Children Under 2 Years
- Cough and cold medications should not be administered to children <2 years without consulting a healthcare provider due to risks of toxicity and lack of FDA-approved dosing recommendations 8
- Dextromethorphan is not recommended for children <4 years of age per FDA labeling 4
Children 4-12 Years
- Dextromethorphan dosing: 2.5-5 mL every 12 hours for ages 4-6 years; 5 mL every 12 hours for ages 6-12 years 4
- Honey may be more effective than placebo in children over a three-day period 9
Elderly Patients
- Dextromethorphan 30-60 mg is the safest first-line option for elderly patients 2
- First-generation antihistamines should be avoided in elderly patients with cognitive impairment, urinary retention, or fall risk 2
Red Flags Requiring Medical Evaluation (Not Just Symptomatic Treatment)
- Hemoptysis, breathlessness, or tachypnea 3
- Tachycardia, fever, or abnormal chest examination findings suggesting pneumonia 3
- Cough persisting beyond 3 weeks requires discontinuation of antitussive therapy and full diagnostic workup 2
- Cough with increasing breathlessness (assess for asthma or anaphylaxis) 3
Common Pitfalls to Avoid
- Using subtherapeutic doses of dextromethorphan (<30 mg) 1, 2
- Suppressing productive cough in conditions like pneumonia or bronchiectasis where clearance is essential 3
- Not recognizing that standard OTC dosing is often inadequate for optimal cough suppression 1
- Prescribing antitussives for cough due to upper respiratory infection, where they have limited efficacy 7, 3